Buy Stocks Easy | About Us
July 8, 2020
Buy Stocks Easy | Online Stocks

AXSM


Buy Axsome Therapeutics, Inc. Stock (symbol: AXSM) Easy Online

Company Name: Axsome Therapeutics, Inc.

Symbol: AXSM

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2015

AXSM Current Share Price

Today's AXSM ( Axsome Therapeutics, Inc. ) opening price: $95.7300

Yesterday's AXSM ( Axsome Therapeutics, Inc. ) closing price: $95.3000

Axsome Therapeutics, Inc. Stock ( symbol: AXSM ) Price Chart since IPO (2015):

12 Months Axsome Therapeutics, Inc. Stock ( symbol: AXSM ) Price Chart

Popular Questions about Axsome Therapeutics, Inc. Public Stock ( AXSM )

A: Axsome Therapeutics, Inc. stock symbol (also called stock or share ticker) is AXSM

A: Axsome Therapeutics, Inc. IPO (Initial Public Offering) took place on 2015

A: Axsome Therapeutics, Inc.'s stock (AXSM symbol) price at ther IPO (initial Public Offering) was $95.7300

Q: Is AXSM stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Axsome Therapeutics, Inc. stock (symbol: AXSM) at the beginning of 2019, at the opening share price of $8.3900, with a minimum of $200, by now your shares would be worth $4966 and your profit would be $4766 - SHOW ONLY IF PROFIT.

Buy Axsome Therapeutics, Inc. Stock Easy Online

Axsome Therapeutics, Inc. Stock Ticker Price Chart since IPO:





Axsome Therapeutics, Inc. Stock Price Yesterday



 


Axsome Therapeutics, Inc. Stock Price – Last Week




 


Axsome Therapeutics, Inc. Stock Price – Last Month




 


Axsome Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/17/1961467/0/en/Axsome-Therapeutics-Added-to-NASDAQ-Biotechnology-Index.html
                            

                                
Axsome Therapeutics Added to NASDAQ Biotechnology Index

                                
                                
NEW YORK, Dec.  17, 2019  (GLOBE NEWSWIRE) -- Axsome Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/node/14995771
                            

                                
High Flying Biotech Axsome Skyrockets On Positive Late-Stage Results For Depression Drug

                                
                                
Shares of Axsome Therapeutics Inc (NASDAQ: AXSM), the best-performi...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/axsome-shares-jump-on-positive-findings-for-depression-drug-2019-12-16
                            

                                
Axsome shares jump on positive findings for depression drug

                                
                                
Shares of Axsome Therapeutics AXSM, -3.66% rocketed 82% in premarke...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/12/16/3-biotech-stocks-with-big-incoming-catalysts.aspx
                            

                                
3 Biotech Stocks With Big Incoming Catalysts

                                
                                
Investors expect stock-moving news from all of these drugmakers bef...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1960786/0/en/Axsome-Therapeutics-Announces-AXS-05-Achieves-Primary-Endpoint-in-GEMINI-Phase-3-Trial-in-Major-Depressive-Disorder.html
                            

                                
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in GEMINI Phase 3 Trial in Major Depressive Disorder

                                
                                
Demonstrated rapid, durable, and statistically significant improvem...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4311382-last-minute-look-axsminus-05-revealed-axsome-therapeutics-may-better-risk-reward-profile-in
                            

                                
A Last-Minute Look At AXS-05 Revealed That Axsome Therapeutics May Have A Better Risk/Reward Profile In Its Major Depressive Disorder Pipeline

                                
                                
A Last-Minute Look At AXS-05 Revealed That Axsome Therapeutics May ...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/14931993/12-biotech-stocks-primed-for-a-short-squeeze
                            

                                
12 Biotech Stocks Primed For A Short Squeeze

                                
                                
Biotech investment is risk fraught. Most biotech stocks are at the ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/653925/axsome-narcolepsy-candidate-meets-phase-ii-goal-stock-up
                            

                                
Axsome Narcolepsy Candidate Meets Phase II Goal, Stock Up

                                
                                
Axsome (AXSM) announces data from a phase II study evaluating AXS-1...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/15019464/4-momentum-stocks-to-watch
                            

                                
4 Momentum Stocks To Watch

                                
                                
These four stocks are moving on news and gaining technical momentum...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962709/0/en/Axsome-Therapeutics-Announces-Pricing-of-Public-Offering-of-174-Million-of-Shares-of-Common-Stock.html
                            

                                
Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock

                                
                                
NEW YORK, Dec.  19, 2019  (GLOBE NEWSWIRE) -- Axsome Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/18/1962465/0/en/Axsome-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html
                            

                                
Axsome Therapeutics Announces Proposed Public Offering of Common Stock

                                
                                
NEW YORK, Dec.  18, 2019  (GLOBE NEWSWIRE) -- Axsome Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/17/1961467/0/en/Axsome-Therapeutics-Added-to-NASDAQ-Biotechnology-Index.html
                            

                                
Axsome Therapeutics Added to NASDAQ Biotechnology Index

                                
                                
NEW YORK, Dec.  17, 2019  (GLOBE NEWSWIRE) -- Axsome Therapeutics, ...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/node/14995771
                            

                                
High Flying Biotech Axsome Skyrockets On Positive Late-Stage Results For Depression Drug

                                
                                
Shares of Axsome Therapeutics Inc (NASDAQ: AXSM), the best-performi...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/axsome-shares-jump-on-positive-findings-for-depression-drug-2019-12-16
                            

                                
Axsome shares jump on positive findings for depression drug

                                
                                
Shares of Axsome Therapeutics AXSM, -3.66% rocketed 82% in premarke...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.